-
Researchers create a single-cell framework to potentially enhance CAR T–cell therapy
07/06/2022
St. Jude scientists developed a method that could improve CAR T-cell therapies by identifying the early cells that become effective at killing cancer.
-
Arkansas State Rep. Dwight Tosh honored at St. Jude for 60-year survival of childhood cancer
06/24/2022
Tosh is the first St. Jude patient to reach this milestone and was recognized at institution’s 60th anniversary celebration
-
St. Jude collaborates with multiple organizations to expand STEM opportunities in Memphis
06/23/2022
New collaboration with multiple organizations is part of national effort to provide equity in STEM education.
-
Pushing T cells down “memory lane” may improve cancer therapy
06/22/2022
St. Jude immunologists identified proteins that help decide T cell fate and used the finding to improve CAR-T cell therapy in a solid tumor model.
-
St. Jude Children’s Research Hospital tops list of most trusted nonprofits
06/17/2022
Nonprofits are featured for the first time in a survey of most trusted brands.
-
Philanthropy cards a hole-in-one for St. Jude Children’s Research Hospital during FedEx St. Jude Championship
06/16/2022
Tournament officials recently announced a charitable impact figure of over $8.6 million was generated for the hospital from the 2021 event.
-
U.S. News & World Report ranks St. Jude as outstanding pediatric cancer hospital
06/14/2022
St. Jude Children’s Research Hospital recognized among hospitals delivering exceptionally high-quality care
-
A high-risk pair – a drug and DNA variant increase heart disease risk in cancer survivors
06/13/2022
St. Jude scientists identified a genetic difference in childhood cancer survivors treated with chemotherapy that predisposes them to heart problems as adults.
-
Unfreezing waters in ligand binding sites
06/07/2022
St. Jude scientists are studying how the temperature at which protein structures are captured can create "artifacts," – errors that cause misleading results.
-
St. Jude Memphis Marathon Weekend general registration opens June 1, challenges and fundraising goals set to support St. Jude Children’s Research Hospital
06/01/2022
Runners, supporters and volunteer fundraisers will sprint toward a fundraising goal of $14 million to benefit St. Jude kids during this fitness event on Saturday, December 3.
-
St. Jude research highlighted at annual meeting of the American Society of Clinical Oncology
05/31/2022
Learn best practices and hear insights from St. Jude oncologists, psychologists and scientists at the annual gathering of clinical oncology experts.
-
Monster Jam® unveils 12,000-pound monster truck custom designed by St. Jude patient, limited-edition collectible to benefit St. Jude Children’s Research Hospital
05/23/2022
Feld Entertainment surprised St. Jude patient Calvin by unveiling his artwork on a truck named Emoji Strong during its Monster Jam World Finals® in Orlando, Florida.
-
Killer T vs. memory – DNA isn’t destiny for T cells
05/20/2022
St. Jude scientists uncovered how one type of T cell creates two genetically identical, but functionally different, daughter cells.
-
Research reveals surprising inactivation mechanism for a voltage-gated ion channel
05/20/2022
This the first time researchers have identified the mechanism for closed-state inactivation. These approaches could be applied to other ion channels.
-
ZBP1 links interferon treatment and dangerous inflammatory cell death during COVID-19
05/19/2022
St. Jude scientists identified ZBP1 as a key contributor to the inflammatory cell death that drives morbidity and mortality in COVID-19 patients.
-
St. Jude Mom Boss Summit celebrates strength and community amid challenges of motherhood, work, wellness
05/12/2022
Hundreds of influencers, business leaders, entrepreneurs and supporters of St. Jude convened in a virtual gathering on Thursday, May 5, for the annual St. Jude Mom Boss Summit.
-
Updates on gene therapy for ‘bubble boy’ disease and cellular immunotherapy at ASGCT
05/12/2022
St. Jude scientists will discuss research on cellular therapies for pediatric cancer and more at the annual meeting.
-
A tool to unlock the ‘numbers game’ of big data in rare disease research
05/11/2022
Big data can cause big problems in rare disease genetics research. Scientists at St. Jude created a systematic solution to find the inherited genes contributing to rare disease.
-
Strategy overcomes EZH2 inhibitor resistance in SMARCB1 mutated cancer
05/09/2022
Findings from St. Jude demonstrate the role of chromatin regulation in cancer’s resistance to EZH2 inhibitors and offer a way to make treatment more effective.
-
Run Rich Run kicks off 60 Days for St. Jude during 60th anniversary of St. Jude Children’s Research Hospital
05/03/2022
In its 18th year, Emmy-nominated NFL Network host Rich Eisen kicked off his annual event at the Rose Bowl, in Pasadena, California.
-
Lab findings suggest EGFR inhibitors may prevent rhabdomyosarcoma recurrence
04/27/2022
RMS is the most common soft tissue sarcoma in children. When it recurs after therapy, the survival rate is only 30%.
-
Single-molecule techniques illuminate mechanisms of GPCR activation
04/27/2022
St. Jude scientists and their Columbia University collaborators reveal how GPCR signaling is regulated with implications for drug development.
-
Study finds jumping “junk” DNA is a novel cause of childhood brain cancer
04/22/2022
St. Jude scientists have found the first known example of a promoter ‘donation’ event from a retrotransposon causing a highly malignant childhood brain cancer.
-
J. Paul Taylor, M.D., Ph.D., named scientific director and executive vice president of St. Jude
04/18/2022
Dr. Taylor steps into the role during a pivotal time of growth for St. Jude, as its scientific enterprise will significantly expand.
-
Tri Delta beats the clock to raise $60 million for St. Jude Children’s Research Hospital
04/14/2022
International women’s organization and longtime partner Tri Delta completed its 10-year, $60 million fundraising commitment two years ahead of schedule.
-
American Society of Clinical Oncology honors St. Jude clinical brain tumor researcher
04/12/2022
Dr. Amar Gajjar becomes the seventh St. Jude Children’s Research Hospital investigator to receive the Pediatric Oncology Award
-
Dr. Martine Roussel recognized for groundbreaking work
04/10/2022
The AACR also honored the St. Jude scientist for her contributions to advancing women in science.
-
St. Jude researchers honored for contributions to treatment of pediatric blood disorders
04/06/2022
St. Jude researchers are recognized by the American Society of Pediatric Hematology/Oncology for their expertise and career achievements
-
Immune responses support COVID-19 vaccination regardless of when people were infected
04/05/2022
St. Jude scientists have studied how vaccination before and after primary infections affect the immune response.
-
St. Jude at the American Association for Cancer Research Annual Meeting
03/30/2022
Scientists from St. Jude Children’s Research Hospital will participate in the annual gathering of a premier professional society for the cancer research community.
